These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29200078)

  • 1. Sugammadex and Oral Contraceptives: Is It Time for a Revision of the Anesthesia Informed Consent?
    Corda DM; Robards CB
    Anesth Analg; 2018 Feb; 126(2):730-731. PubMed ID: 29200078
    [No Abstract]   [Full Text] [Related]  

  • 2. Informed Consent for Sugammadex and Oral Contraceptives: Through the Looking Glass.
    Webber AM; Kreso M
    Anesth Analg; 2018 Sep; 127(3):e52. PubMed ID: 29979198
    [No Abstract]   [Full Text] [Related]  

  • 3. Approaches to Patient Counseling Regarding Effectiveness of Oral Contraceptives.
    DeAndrade DS; Berman JR; Boisen ML
    Anesth Analg; 2018 May; 126(5):1789. PubMed ID: 29461388
    [No Abstract]   [Full Text] [Related]  

  • 4. Sugammadex and oral contraceptives.
    Devoy T; Smith N
    Curr Opin Anaesthesiol; 2024 Aug; 37(4):338-343. PubMed ID: 38841921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex - time of onset: nine months.
    Dalton J; Van Hasselt G
    Anaesthesia; 2016 Jan; 71(1):115-6. PubMed ID: 26684534
    [No Abstract]   [Full Text] [Related]  

  • 6. In Response.
    Corda DM; Robards CB
    Anesth Analg; 2018 May; 126(5):1789. PubMed ID: 29461390
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Train-of-four recovery precedes twitch recovery during reversal with sugammadex in pediatric patients: A retrospective analysis.
    Vieira Carlos R; Luis Abramides Torres M; de Boer HD
    Paediatr Anaesth; 2018 Apr; 28(4):342-346. PubMed ID: 29399936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
    de Boer HD; Carlos RV; Brull SJ
    BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist.
    Hemmerling TM; Zaouter C; Geldner G; Nauheimer D
    Ann Card Anaesth; 2010; 13(3):206-16. PubMed ID: 20826961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives.
    Carron M; Bertoncello F; Ieppariello G
    Clin Interv Aging; 2018; 13():13-24. PubMed ID: 29317806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.
    Abd El-Rahman AM; Othman AH; El Sherif FA; Mostafa MF; Taha O
    Minerva Anestesiol; 2017 Feb; 83(2):138-144. PubMed ID: 27575450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex: A Review of Neuromuscular Blockade Reversal.
    Keating GM
    Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It blew my mind": exploring the difficulties of anesthesia informed consent through narrative.
    Shafer A
    Anesthesiology; 2009 Mar; 110(3):445-6. PubMed ID: 19204561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.